Can Vyne Therapeutics Stock Keep Soaring?
Shares of beaten-down biotech stock Vyne Therapeutics (NASDAQ: VYNE) jumped more than 30% higher on Jan. 25, 2021, in response to a relatively minor development for its new acne treatments. In a nutshell, the company executed a contract that could boost sales of its recently launched products.
Millions of teenagers and adults eager to prevent spots from erupting on their faces could push sales of Vyne Therapeutics' new treatments through the roof. That said, independent new drug launches rarely progress as quickly as investors expect.
Image source: Getty Images.
Source Fool.com
